Professor, Internal Medicine, Mayo Medical School
Infectious Disease
Dr. Raymund R. Razonable, MD
|
|
Give Review
Raymund Razonable works in the field of Infectious Disease. He received awards:"Mayo Clinic Quality Fellow: Bronze Level Certification", "Fellow", "Clinical Infectious Diseases Award for Outstanding Review", "ICAAC/IDSA Joint Program Committee Award for Immunology of Infection", "ICAAC Program Committee Award in the Pathogenesis of Microbial Diseases", "ASM Infectious Disease Fellow", "Internal Medicine Awards, Geraci Award for Outstanding Achievement in Infectious Diseases", "Summerskill Award Nominee for outstanding achievement in research by a trainee in a subspecialty clinical program, Department of Internal Medicine", "Scholar, Division of Infectious Diseases, Department of Internal Medicine", "Special Citation for the Caliber of Abstract Presentations", "Best Scientific Poster Award", "Alexander Award for the Most Outstanding Medical Resident", "Medical Board Topnotcher. Garnered Highest Score (91.17%) Among 1930 Physicians", "Most Outstanding Medical Graduate", "Rolando Solis Award for Excellence in Cardiology", "Most Outstanding Intern", "Dalmacio and Eusebia de Roca Award for Excellence in Pediatrics", "Lucila Fernando Relucio Award for Academic Excellence During the First 3 Years of Medical School", "Scholar in Medicine", "Cesar V Nolasco Award for Excellence in Pharmacology", "Edgar A Borda Award for Excellence in Biochemistry", "Edwin Nolasco Award for Excellence in Gross Anatomy", "Rodolfo Madlang Award for Excellence in Physiology", "Special Citations for academic excellence in the fields of Histology, Pathology, Laboratory Diagnosis, Microbiology, Parasitology, Surgery and Neurology", "Academic Scholar", "Dean's List", "Special Citations for Academic Excellence in Histology and Anatomy", "Most Proficient Intern in Medical Technology" and "Academic Scholarship". Raymund Razonable is a published physician. He has 101 papers published. The most current publication "Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions i..." He is registered with Medicare and accepts Medicare payments.
Publications
- A Survey of Infection Prevention and Control Practices among Hematopoietic Stem Cell Transplant Centers.
- Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions i...
- Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.
- Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
- Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities.
- Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
- Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a Lung Transplant Patient.
- Management of cytomegalovirus infection and disease in liver transplant recipients.
- Rhodococcus globerulus bacteremia in an allogeneic hematopoietic stem cell transplant recipient: report of the first transplant case and review of the literature.
- Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation.
- Viridans Group Streptococci in Febrile Neutropenic Cancer Patients: What Should We Fear?
- Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
- Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
- Impact of urinary tract infection on allograft function after kidney transplantation.
- Elizabethkingia species sepsis after lung transplantation: case report and literature review.
- Reply to Soteriadou et al.
- Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation.
- Opportunistic Infections Due to Inflammatory Bowel Disease Therapy.
- Cytomegalovirus Infections in Solid Organ Transplantation: A Review.
- A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
- Diagnostic and Management Strategies for Donor-derived Infections.
- Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients.
- Cytomegalovirus in solid organ transplantation.
- Virologic Suppression Measured by a CMV DNA Test Calibrated to the WHO International Standard is Predictive of CMV Disease Resolution in Transplant Recipients.
- Human herpesviruses 6, 7 and 8 in solid organ transplant recipients.
- Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
- Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study.
- An approach to transplant recipients with skin lesions.
- Chromosomally integrated human herpesvirus-6 in transplant recipients.
- Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.
- Homozygosity for the Toll-Like Receptor 2 R753Q Single-Nucleotide Polymorphism Is a Risk Factor for Cytomegalovirus Disease After Liver Transplantation.
- Rare, unusual, and less common virus infections after organ transplantation.
- Reply to "May the Indirect Effects of CIHHV-6 in Transplant Patients be Exerted Through the Reactivation of the Viral Replicative Machinery?".
- Chromosomally integrated human herpesvirus 6: questions and answers.
- Human herpes virus 8 in solid organ transplantation.
- Mycobacterium wolinskyi: a case series and review of the literature.
- Epidemiology of Cytomegalovirus Infection After Pancreas Transplantation.
- Toll-Like Receptor 4 Polymorphisms and the Risk of Gram-Negative Bacterial Infections After Liver Transplantation.
- A scoring model of factors associated with Candida glabrata candidemia among critically ill patients.
- Clinical Significance of Pretransplant Chromosomally Integrated Human Herpesvirus-6 in Liver Transplant Recipients.
- Chromosomally integrated human herpesvirus-6 in kidney transplant recipients.
- Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation.
- Critical care issues in patients after liver transplantation.
- Impact of Gram-Negative Bloodstream Infection on Long-Term Allograft Survival After Kidney Transplantation.
- Spectrum of early- and late-onset bacteremia after liver transplantation: Implications for management.
- Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
- Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis.
- Infections due to human herpesvirus 6 in solid organ transplant recipients.
- Serious infections caused by methicillin-resistant Staphylococcus aureus.
- Innate immune genetic profile to predict infection risk and outcome after liver transplant.
- A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human Toll-like receptor 3 gene.
- R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins.
- Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.
- Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.
- The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus.
- Capnocytophaga canimorsus a novel pathogen for joint arthroplasty.
- Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy?
- Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.
- Delayed-onset primary cytomegalovirus disease after liver transplantation.
- Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients.
- A young man with pyomyositis and bullous disease.
- Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature.
- Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus.
- Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy.
- Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation.
- JC Virus Infection After Transplantation: Beyond the Classic Progressive Multifocal Leukoencephalopathy?
- Toll-like receptor-2 Arg753Gln polymorphism and herpes virus infections in transplantation.
- Parvovirus B19 infection after transplantation: a review of 98 cases.
- Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines.
- Effacing of the T cell compartment by cardiac transplantation in infancy.
- Primary cytomegalovirus disease after five years of antiviral prophylaxis.
- Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism.
- Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.
- Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2.
- Linezolid therapy for orthopedic infections.
- Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess.
- Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.
- The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.
- The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation.
- Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
- Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
- The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.
- Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.
- Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts.
- Cytomegalovirus infection after liver transplantation: current concepts and challenges.
- Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes.
- A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
- Human herpesvirus 6 infections after liver transplantation.
- The impact of invasive fungal diseases on survival after lung transplantation.
- Current concepts on cytomegalovirus infection after liver transplantation.
- Impact of human herpes virus 6 in liver transplantation.
- Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States.
- Unrecognized pretransplant and donorâderived cryptococcal disease in organ transplant recipients.
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.
- Immune-based therapies for cytomegalovirus infection.
- Strategies for managing cytomegalovirus in transplant recipients.
- New developments in the management of cytomegalovirus infection after solid organ transplantation.
- Cutaneous cryptococcosis in solid organ transplant recipients.
- An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
- Graft-vs.-host disease in lung and other solid organ transplant recipients.
Schools
Far Eastern UniversityNicanor Reyes Medical Foundation
Beth Israel Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Mayo Clinic Quality Fellow: Bronze Level Certification
- Fellow
- Clinical Infectious Diseases Award for Outstanding Review
- ICAAC/IDSA Joint Program Committee Award for Immunology of Infection
- ICAAC Program Committee Award in the Pathogenesis of Microbial Diseases
- ASM Infectious Disease Fellow
- Internal Medicine Awards, Geraci Award for Outstanding Achievement in Infectious Diseases
- Summerskill Award Nominee for outstanding achievement in research by a trainee in a subspecialty clinical program, Department of Internal Medicine
- Scholar, Division of Infectious Diseases, Department of Internal Medicine
- Special Citation for the Caliber of Abstract Presentations
- Best Scientific Poster Award
- Alexander Award for the Most Outstanding Medical Resident
- Medical Board Topnotcher. Garnered Highest Score (91.17%) Among 1930 Physicians
- Most Outstanding Medical Graduate
- Rolando Solis Award for Excellence in Cardiology
- Most Outstanding Intern
- Dalmacio and Eusebia de Roca Award for Excellence in Pediatrics
- Lucila Fernando Relucio Award for Academic Excellence During the First 3 Years of Medical School
- Scholar in Medicine
- Cesar V Nolasco Award for Excellence in Pharmacology
- Edgar A Borda Award for Excellence in Biochemistry
- Edwin Nolasco Award for Excellence in Gross Anatomy
- Rodolfo Madlang Award for Excellence in Physiology
- Special Citations for academic excellence in the fields of Histology, Pathology, Laboratory Diagnosis, Microbiology, Parasitology, Surgery and Neurology
- Academic Scholar
- Dean's List
- Special Citations for Academic Excellence in Histology and Anatomy
- Most Proficient Intern in Medical Technology
- Academic Scholarship
Education
-
Mayo School of Graduate Medical Education -
Mount Sinai Beth Israel -
Far Eastern University Nicanor Reyes Medical Foundation
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1750351805 | |
| NPPES Provider LastName | RAZONABLE | |
| NPPES Provider FirstName | RAYMUND | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750351805 |
| Last Name Of The Provider | RAZONABLE |
| First Name Of The Provider | RAYMUND |
| View All |
Similar Doctors
|
|
Dr. Jakrapun Pupaibool, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew D. Badley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan W. Cummins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmad R. Nusair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Franklin R. Cockerill III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall C. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahul Sampath, MD
This Doctor is OpenDoctor Recommended.
|